[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
[ Fri, Nov 17th 2023 ]: WOPRAI
Ed Arce Maintained (AKBA) at Strong Buy with Increased Target to $5 on, Nov 17th, 2023
- 🞛 This publication is a summary or evaluation of another publication
Ed Arce of HC Wainwright & Co., Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Increased Target from $3.75 to $5 on, Nov 17th, 2023.
Ed, nor any peers, have made any analyst calls on AKBA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30